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Summary
Objective: Pleiotrophin (PTN) is a secreted heparin-binding peptide expressed in mesodermal and neuroectodermal cells during development,
but rarely in adult tissues. In fetal and juvenile, but not in mature cartilage, PTN is abundant. Furthermore, PTN is re-expressed in chondro-
cytes in early stages of osteoarthritis (OA). Since little is known about the functions of PTN in cartilage, we investigated the occurrence of PTN
receptors in human articular cartilage in situ and PTN effects on human primary and immortalized chondrocytes in vitro.
Methods: Receptor expression and regulation was monitored by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and
immunohistochemistry. PTN effects and signal transduction were studied by electrophoretic mobility shift, Boyden chamber cell migration and
proliferation assays, effects on gene expression by real time RT-PCR and that on nitric oxide (NO) by the Griess reaction.
Results: Of the putative PTN signaling receptors, immortalized and primary chondrocytes (pc) expressed the anaplastic lymphoma kinase
(ALK), less the receptor-type protein tyrosine phosphatase z/b (PTPz). ALK expression was upregulated upon ligand exposure. PTN stimu-
lation activated the AP-1 (activator protein-1) transcription factor and altered gene expression. Prolonged stimulation induced PTN mRNA
expression slightly, reduced vascular endothelial growth factor (VEGF) mRNA as well as NO production. Whereas mRNA expression of
matrix metalloproteinases (MMPs) MMP-1 and MMP-13 was reduced, their inhibitors TIMP-1 and TIMP-2 were induced. Furthermore, PTN
stimulated chondrocyte migration and proliferation.
Conclusions: These results show that PTN is an autocrine growth factor in cartilage. We suggest that PTN may be involved in the clustering
and proliferation of chondrocytes observed in the early stages of OA.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Pleiotrophin (PTN), also known as heparin-binding growth-
associated molecule (HB-GAM), heparin-binding growth
factor 8, heparin-binding neurotrophic factor (HBNF) and
osteoblast-speciﬁc protein-1 (OSF-1), is an 136-amino
acid (15.3 kDa) secreted growth/differentiation cytokine
that is developmentally regulated (for reviews, see Refs.
1e4). Mature PTN is a non-glycosylated, lysine-rich peptide
that is derived from an 168 residue precursor with a 32-
amino acid signal sequence. PTN is a differentiation or
growth factor for various cell types (therefore named pleio-
trophin): it has mitogenic, anti-apoptotic, transforming,
angiogenic and chemotactic biological activities that can
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Received 28 October 2005; revision accepted 13 July 2006.155differ between its target cells. Together with midkine (MK)
it forms a family of heparin-binding proteins that are nor-
mally expressed during embryogenesis, but only at low
levels in healthy adult tissues.
Both, PTN and MK bind with high-afﬁnity to extracellular
heparan-sulfate proteoglycans as well as to cell surface syn-
decans, LDL receptor-related protein (LRP), anaplastic lym-
phoma kinase (ALK), and the receptor-type protein tyrosine
phosphatase z/b (PTPz). However, signaling effects appear
to bemediated only by ALK and PTPz and include phosphor-
ylation of phosphatidylinositol-3-kinase (PI3-kinase), extra-
cellular-signal related kinases (Erk) and further intracellular
proteins like b-catenin that is involved in the transcription
and the transformation of the cytoskeletal architecture5e8.
Previous studies have mostly focused on PTN/MK effects
in neurons and neurite outgrowth, osteoblasts and bone
formation, ﬁbroblast and neutrophil activation in chronic
inﬂammatory diseases like rheumatoid arthritis, cancer
cells and cancer angiogenesis1e4,9,10. However, less is
known about their functions in cartilage, despite PTN is an
abundant protein in fetal and juvenile, but not in adult cartilage
except in early stages of osteoarthritis (OA)11e14. Therefore,
with immortalized and primary human chondrocytes as
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tors, PTN-mediated signal transduction pathways, and PTN
effects on chondrocytes. Prolonged (24 h) PTN exposure
regulated the gene expression of PTN, vascular endothelial
growth factor-A (VEGF-A, in the subsequent text simply
termed VEGF), matrix metalloproteinases (MMPs) and their
endogenous tissue inhibitors (TIMPs) in diverse ways. Fur-
thermore, PTN reduced nitric oxide (NO) production and in-
duced chondrocyte chemotaxis as well as proliferation.
Thus, PTN appears to be a novel autocrine factor in cartilage
with mainly protective functions.
Materials and methods
CELL CULTURES AND PEPTIDES
For most experiments we used immortalized human cos-
tal chondrocytes (C28/I2) which have been previously char-
acterized to express collagen type II and aggrecan strongly,
lesser collagen X. Furthermore, they produce MMPs MMP-
1, MMP-3 and MMP-13 that can be induced by interleukin-
1b (IL-1b), and VEGF. These differentiated chondrocytes
were cultured as described15e18. Primary articular chondro-
cytes for veriﬁcation of the C28/I2 experiments were derived
from elderly patients (67e80 years) undergoing joint re-
placement due to fracture. These ‘‘normal’’ chondrocytes
produce strong amounts of collagen type II as well as slight
amounts of collagen X indicating early OA changes. They
were obtained from Oligene (Berlin, Germany). Cells
were shipped proliferating and were expanded into ﬁve sub-
cultures at densities of 500,000 cells per ﬂask for further ex-
periments. The company vouches for given consent of the
patient. The glioma cell line U343 (Deutsches Krebsfor-
schungszentrum, Heidelberg, Germany) served as positive
control19. Recombinant human PTN and other cytokines/
growth factors were from PepproTech (Rocky Hill, NJ,
USA).
TISSUES
Tibial plateaus were obtained from patients with OA who
underwent joint replacement (Clinic for Orthopedic Surgery,
University of Kiel, Germany), and normal cartilage was ob-
tained from body donors (Department of Anatomy). From
the center of each side, a biopsy of normal cartilage and
subchondral bone was taken and the tissue was ﬁxed in
4% formaldehyde in phosphate-buffered saline (PBS), pH
7.4, for histological and immunohistochemical analyses.
Total RNA was extracted from crushed cartilage with the
RNeasy Total RNA Kit (Qiagen, Hilden, Germany) as
described20. The glioblastoma multiforme samples were
obtained from patients who underwent neurosurgery (De-
partment of Neurosurgery, University of Kiel, Germany).
All human samples were obtained with the patients’ or do-
nors’ consent, the permission of the responsible committee
of the University of Kiel and in accordance with the Helsinki
Declaration of 1975.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
Specimens were decalciﬁed in 10% ethylenediaminete-
traacetic acid (EDTA) at 40C for several days until X-ray
examination revealed complete decalciﬁcation. Then,
sections were dehydrated and embedded in parafﬁn. De-
parafﬁnized 8 mm sections were stained with toluidine blue
and examined by light microscopy. The stage of OA was
classiﬁed using the score according to Mankin. Forimmunohistochemistry, sections were dewaxed, incubated
with testicular hyaluronidase (2 mg/ml in PBS, pH 5.0, for
30 min at room temperature) and pronase (1 mg/ml in
PBS, pH 7.4, 30 min at room temperature)20. For chromo-
genic immunostaining, sections were incubated with anti-
ALK (1:40; rabbit polyclonal, 51-3900 from Zymed, San
Francisco, CA, USA) followed by biotinylated secondary an-
tibodies and a peroxidase-labeled streptavidinebiotin stain-
ing technique; nuclei were counterstained with hemalum20.
Controls were performed either by omitting the primary an-
tibody or by absorption of the primary antibody to recombi-
nant human ALK (2 mg/500 ml) overnight at 4C.
RNA PREPARATION, cDNA synthesis, and real time PCR
Cells cultivated in medium containing 10% fetal calf
serum (FCS) for 3 days (80% conﬂuence) were exposed
to stimulators for 24 h in serum-free medium after 4 h pre-
incubation with only serum-free medium. Total RNA was
extracted with the RNeasy Total RNA Kit (Qiagen, Hilden,
Germany), contaminating DNA destroyed by digestion
with RNase-free DNase-I (20 min at 25C; Boehringer,
Mannheim, Germany), and cDNA generated from 100 ng
RNA with 1 ml (20 pmol) of oligo(dT)15 primer (Amersham
Biosciences, Amersham, UK) and 0.8 ml of superscript
RNase H-reverse transcriptase (Gibco, Paisley, UK) in
50 ml for 60 min at 37C21. For each sample, a control with-
out reverse transcriptase was run parallel to allow assess-
ment of genomic DNA contamination.
Fig. 1. Expression of mRNA for PTN and its putative signaling re-
ceptors ALK and receptor-type PTPz in human cartilage tissue
samples (A) and their regulation in cultivated chondrocytes (B) as
determined by real time RT-PCR. (A) Samples of healthy articular
cartilage (control) show a low expression of PTN, whereas in surgi-
cal sample from OA patients PTN and ALK are considerably higher.
Donors: n¼ 6 SD. (B) Immortalized human chondrocytes and pc
were stimulated for 24 h with/without PTN at increasing concentra-
tions, and ALK mRNA expression was monitored by quantitative
RT-PCR. n¼ 6SD; P 0.01 control vs PTN.
157Osteoarthritis and Cartilage Vol. 15, No. 2Fig. 2. Immunohistochemistry of ALK protein in early OA cartilage (AeC) and a glioma sample (D) used as the positive control. By chromo-
genic staining, ALK is detected in superﬁcial chondrocytes in situ (A, B); negative control (C). Bar¼ 100 mm (A); bar¼ 10 mm (BeD).Each cDNA sample was analyzed for expression of the
gene of interest as well as glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) by real time quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR) using
the ﬂuorescent TaqMan 50-nuclease assay using 2 Taq-
Man Master Mix (Applied Biosystems, Foster City, CA)
and 20 assay-on-demand TaqMan primers and probes
in a total volume of 20 ml21. The mRNA level for the gene
of interest was quantiﬁed as the percentage of that
determined for GAPDH. For this purpose CT values for
the gene of interest and GAPDH were determined. From
these, DCT values were calculated as CTGAPDHCTgene
of interest and results were then expressed as 2
DCT 100.
TaqMan human primers and probes had the followingidentiﬁcation numbers: PTN: Hs00383235_m1; PTPz: Hs00
267839_m1; ALK: Hs00608289_m1; VEGF: Hs00173
626_m1; MMP-1: Hs00233958_m1; MMP-13: Hs00233
992_m1; TIMP-1: Hs00171558_m1; TIMP-2: Hs002342
78_m1; GAPDH: Hs99999905_m1.
ELECTROPHORETIC MOBILITY SHIFT ASSAY (EMSA)
Subconﬂuent C28/I2 chondrocytes (5 106 cells) were
stimulated with PTN (10 ng/ml) for 0e6 h in serum-free
medium (after 3 h pre-equilibration with serum-free medium),
lysed, nuclei prepared, nuclear proteins extracted, and 5 mg
aliquots incubated with 1 ml 32P-labeled oligonucleotide
probes (30,000e60,000 cpm/ml) for 30 min at 4C as
158 T. Pufe et al.: Pleiotrophin and chondrocytesdescribed22. The complexes were separated on non-
denaturing 4% polyacrylamide gels at 20C and 140 V for
1.5 h, and autoradiographs quantiﬁed.
DETERMINATION OF NITRITE/NITRATE
Subconﬂuent C28/I2 chondrocytes (5 105 cells) were
stimulated for 24 h in medium with 10% FCS with/without re-
combinant epidermal growth factor 10 ng/ml (EGF; Peppro
Tech, Rocky Hill, NJ, USA) or PTN 10 ng/ml. In the culture
supernatants, nitrite/nitrate oxidized from NO was measured
spectrophotometrically by the Griess reaction (Sigmae
Aldrich G-4410).
TRANSFILTER ASSAYS
For transﬁlter assays, polycarbonate membranes (Neuro
Probe, Baltimore, MD, USA) with a pore size of 5 mm were
washed in acetic acid and then in distilled water. In 48-well
chambers, the lower chamber was ﬁlled with medium plus
0.5% bovine serum albumin supplemented without/with 1,
10 or 100 ng/ml recombinant PTN. After 12 or 24 h, cells
were carefully wiped off the upper side of the membranes;
those migrated into/through them ﬁxed with methanol and
stained with hematoxylin. Results were quantiﬁed by digitiz-
ing stained membranes on a high resolution scanner and bi-
narizing the images along a threshold deﬁned by the grey
value of the ﬁlter material into which cells have migrated.
PROLIFERATION ASSAYS
C28/I2 chondrocytes (1 105) or primary articular chon-
drocytes per 25-cm2 dish were grown to 30% conﬂuence
in culture medium containing 10% FCS. After changing to
serum-free medium plus 0.5% bovine serum albumin, cells
were stimulated for 72 h without/with 1, 10, or 100 ng/ml
PTN in the presence of 3H-thymidine in the last 24 h (Amer-
sham Biosciences; 125 mCi/ml), and incorporation was
monitored as described19.
Fig. 3. PTN-induced activation of the transcription factor AP-1 in im-
mortalized chondrocytes. Cells were stimulated in duplicate with/
without 10 ng/ml PTN for each time point, nuclei isolated, and
nuclear extracts were analyzed by EMSAs (top: autoradiogram of
duplicate individual samples, bottom: densitometry of the bands).
Strong AP-1 shift is visible after 3e6 h. OD¼ optical density.STATISTICAL ANALYSIS
Differences between the PTNand control groupwere eval-
uated using the Dunnet’s control group comparison test.
Group differences were considered signiﬁcant if P 0.01.
Results
EXPRESSION OF mRNA FOR THE SIGNALING RECEPTOR ALK
IN CHONDROCYTES AND ITS INDUCTION BY PTN
By real time RT-PCR we investigated the expression of
the two putative PTN signaling receptors in human OA car-
tilage in situ and in human chondrocytes in vitro. Real time
RT-PCR experiments showed a low mRNA expression of
PTN, ALK and PTPz in normal cartilage whereas in OA car-
tilage PTN as well as ALK were considerably enhanced
[Fig. 1(A)]. In human primary chondrocytes (pc) and in im-
mortalized C28/I2 chondrocytes ALK mRNA could be easily
quantiﬁed by real time RT-PCR, whereas PTPz was not de-
tectable [Fig. 1(B)]. ALK expression in chondrocytes (DCT
15.7) was comparable to those in glioma cells (U118 glioma
cells DCT 14.5, U343 glioma cells DCT 12.2; for equal
amounts of RNA, lower DCT indicates higher expression,
DCT¼ 3.3 corresponds to a 10-fold difference) used as pos-
itive controls19. Prolonged (24 h) stimulation with increasing
PTN concentrations induced ALK mRNA expression about
2.5-fold in C28/I2 cells and about 3-fold in pc [Fig. 1(B)].
IMMUNOHISTOCHEMISTRY OF ALK PROTEIN
By immunohistochemistry, ALK protein could also be
detected on OA chondrocytes in situ (Fig. 2). In particular,
superﬁcial clusters of OA chondrocytes were ALK positive
Fig. 4. Effects of 24 h PTN (10 ng/ml) stimulation on PTN and
VEGF-A mRNA expression in primary and immortalized chondro-
cytes (C28/I2) as determined by quantitative RT-PCR. PTN is
up-, VEGF-A down-regulated. Means of n¼ 3 individual stimula-
tions eachSD; P 0.01 control vs PTN.
159Osteoarthritis and Cartilage Vol. 15, No. 2[Fig. 2(A,B)]. A glioblastoma multiforme grade 4 derived
from neurosurgery served as the positive control
[Fig. 2(D)]. In vitro, immortalized C28/I2 chondrocytes could
be stained for ALK (not shown).
SIGNAL TRANSDUCTION AFTER PTN STIMULATION
Activation of transcription factors was investigated by
EMSAs after PTN stimulation of immortalized chondro-
cytes. Induction of the transcription factor AP-1 (activator
protein-1) was detected that was highest after 3 h and
then ceased [Fig. 3(C)]. Smaller effects were seen for the
activation of the transcription factor Sp-1 (not shown).
These results show that PTN induces the activation of tran-
scription factors which might regulate the gene expression.
PTN EFFECTS ON GENE EXPRESSION OF PRO-INFLAMMATORY
GROWTH FACTORS, MMPs AND THEIR INHIBITORS AS WELL
AS NO PRODUCTION
Therefore, we analyzed the effects of 24 h PTN stimula-
tion on the expression of several genes by quantitative
RT-PCR and chemical determination.In immortalized chondrocytes PTN induced its own
mRNA expression slightly (about 2-fold), but reduced
mRNA of VEGF-A to about one-ﬁfth (Fig. 4). Primary normal
chondrocytes obtained from Oligene (Berlin, Germany) re-
vealed similar results (Fig. 4). VEGF-A is a growth/angio-
genic factor expressed in hypertrophic and OA, but not in
normal adult chondrocytes23,24.
The immortalized (and primary) chondrocytes released
metalloproteinases (MMPs) and tissue inhibitors of metallo-
proteinases (TIMPs) into their culture medium (as deter-
mined by enzyme-linked immunoassays (ELISAs) in ng/
500,000 cells 24 h for immortalized chondrocytes18: MMP-
1 about 125, MMP-13 about 190, TIMP-1 about 197, and
TIMP-2 about 251). As determined by real time RT-PCR,
PTN reduced the MMPs MMP-1 and MMP-13 about half,
but induced somewhat (2-fold) their inhibitors TIMP-1 and
TIMP-2 (Fig. 5). In pc, reduction of MMP-1 and MMP-13 ex-
pressions was even stronger (40 or 50% of controls) than in
immortalized ones. The increase of TIMP-1 and TIMP-2
was nearly equal in C28/I2 and in pc (Fig. 5). In contrast
to PTN, IL-1b induced MMP-1 and MMP-13 about 2-fold
in immortalized chondrocytes. Interestingly, this increase
was reduced substantially by co-incubation with PTN.Fig. 5. Effects of PTN (24 h, 10 ng/ml) alone or in combination with IL-1b on mRNA expression of MMPs MMP-1 (A) and MMP-13 (B) and
their inhibitors TIMP-1 (C) and TIMP-2 (D) as well as on NO (E) production in pc and in immortalized chondrocytes (C28/I2) as determined
by quantitative RT-PCR or by the Griess reaction. MMPs are down-, TIMPs are upregulated. NO is reduced by PTN, but induced by EGF
(10 ng/ml, positive control). PTN reduces the stimulatory effects of IL-1b on MMP expression. Means of n¼ 3 individual stimulations
eachSD; P 0.01 control vs PTN.
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1 with PTN yielded similar effects than with PTN alone.
To test whether inﬂammatory factors are regulated by
PTN, we measured the inﬂuence on nitrate/nitrite produc-
tion after 24 h with the Griess reagent. PTN reduced NO
production to about half of the controls in immortalized
chondrocytes, whereas an increase was seen with EGF
used as a positive control (Fig. 5).
These experiments show that PTN regulates the expres-
sion of several genes in diverse ways. Genes/gene prod-
ucts with pro-inﬂammatory effects (VEGF, NO) or matrix-
degrading activities (MMP-1, MMP-13) were more or less
down-regulated, whereas protective factors like TIMP-1/-2
and PTN itself were slightly upregulated.
PTN EFFECTS ON CHEMOTAXIS AND PROLIFERATION OF
CHONDROCYTES
Besides affecting the gene expression, PTN exerted
stimulatory effects on the migration and proliferation of
primary and immortalized chondrocytes (Fig. 6). In transﬁl-
ter assays, PTN had a slight, but reproducible chemotactic
effect after 24 h. No effect was detectable after 12 h.
The chemotactic effect of pc was little stronger. Further-
more, PTN increased 3H-thymidine incorporation to about
150% of controls in C28/I2 and to about 155% in pc.
Thus, PTN also induces complex cellular responses in
chondrocytes.
Fig. 6. Inﬂuence of PTN on chemotaxis and proliferation of immor-
talized chondrocytes and primary chondrocytes (pc) by PTN. Che-
motaxis was determined by Boyden chamber assays after 24 h,
proliferation by 3H-thymidine incorporation after 72 h. Means of
n¼ 5 individual stimulations eachSD; P 0.01 control vs PTN
100 ng/ml.Discussion
OA is a joint disease that involves degeneration of articular
cartilage and intraarticular inﬂammation manifested by syno-
vitis25,26. Mechanical, biochemical and genetic factors are
implied in the aetiologies of OA. In early stages, it involves
an initial, transient proliferation and clustering of the chon-
drocytes in cartilage ﬁssures associated with an increased
synthesis of cartilage matrix proteins whereas at later stages
cartilage destruction considerable exceeds cartilage
repair25. Several autocrine and paracrine cytokines/growth
factors regulate the catabolic and anabolic processes. Cyto-
kines such as IL-1, TNF-a and VEGF mediate mainly
destructive and inﬂammatory reactions, whereas insulin-
like growth factor-1 (IGF-1), transforming growth factor-
b (TGF-b), or bone morphogenetic proteins (BMPs) favor
the production of extracellular matrix components23e26. Ex-
tracellular matrix degradation is initiated by chondrocyte-
derived proteinases such as MMP-1 (collagenase 1, EC
3.4.24.7), MMP-3 (stromelysin, EC 3.4.24.17), MMP-13 (col-
lagenase 3, EC 3.4.24.-) and aggrecanases (ADAMTS4/5).
In previous studies we have shown that PTN is ex-
pressed in chondrocytes of early OA stages whereas it is
lower in later stages and is absent in normal adult carti-
lage14. In addition, ﬁbroblasts in the synovium of OA pa-
tients produce PTN9, and PTN concentrations are
elevated in synovial ﬂuids of OA patients, in particular in
early stages14. We here show that a PTN receptor is found
on chondrocytes and can be induced by its own ligand.
There is some disagreement with regards to ALK being
the bona ﬁde receptor for PTN27e30 and other receptors/
binding proteins like syndecans or cell surface heparin/
chondroitin sulfate might further contribute to PTN re-
sponses. However, several interesting effects could be
measured after PTN stimulation of chondrocytes in vitro.
Namely, PTN reduces the production of the mainly ‘‘de-
structive’’ cytokine VEGF and the inﬂammatory factor NO
as well as of the extracellular-degrading proteinases
MMP-1 and MMP-13, but induces the ‘‘protective’’ inhibitors
TIMP-1 and TIMP-2. PTN can also reduce the IL-1-medi-
ated induction of these MMPs to control or even lower
levels. PTN upregulates the active transcription factor
AP-1 after 3e6 h, but the participation of other inhibitory
transcription factors is supposable. However, at least the
increase of TIMP-1 and TIMP-2 can be explained as a con-
sequence of AP-1 activation.
PTNmay also participate in the clustering of chondrocytes
during OA. Concluded from these in situ and from in vitro
experiments, PTN expression is a characteristic feature of
early OA stages, and functionally the peptide appears to
be a mainly protective factor favoring cartilage repair.
In accordance, PTN overexpression in mice revealed in-
creased type I collagen deposition by articular chondrocytes
and also an encroachment of subchondral bone into the
articular cartilage31. Similar, long-standing administration
of retinyl acetate in high doses to mice induced PTN in car-
tilage associated with a proliferation of subchondral bone32.
The observations point to further paracrine actions of PTN
to osteoblasts/progenitor cells. PTN is well known to induce
migration, proliferation, differentiation of osteoblasts and
subsequent bone formation during development, but also
bone fracture healing13,33,34.
Despite PTN appears to be an important factor in the
development of the locomotor system, little is known about
PTN receptors, their signal transduction and PTN effects on
chondrocytes (and osteoblasts). PTN has been reported to
be mitogenic for ﬁbroblasts as well as for endothelial and
161Osteoarthritis and Cartilage Vol. 15, No. 2epithelial cells35. In juvenile chondrocytes, recombinant
PTN stimulated extracellular matrix synthesis, in particular
that of biglycan and collagen type II, but not of decorin
and aggrecan36. Osteoblasts migrate rapidly to PTN in
haptotactic transﬁlter assays and other migration assays34.
We could now show that PTN has similar chemotactic and
mitogenic effects on chondrocytes and regulates a variety
of genes in these cells.
Overall, PTN is an additional remodeling factor expressed
in early OA. Its functions appear to be mostly favorable for
cartilage repair, but further pathological features such as
subchondral bone thickening might be also induced.
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